Diamonds and Dogs
Eli Lilly (LLY) jumping on their positive drug news. Lilly is up 10% to new highs thanks to positive phase 2 trial results for their Alzheimer's treatment. Eli Lilly said that donanemab, an investigational antibody, showed a "significant slowing of decline" in a composite measure of cognition and daily function in trial patients suffering early symptomatic Alzheimer's disease. Alzheimer's disease, a progressive brain disorder, affects more than 50 million people around the world.
Twitter (TWTR) and Facebook (FB) trading lower. The stocks are down 6% and 3% as both companies are banning either the President and or political ads. One analyst argues the President could account for 10% earnings for Twitter.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.